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Abstract
Solitary fibrous tumours (SFTs) are fibroblastic mesenchymal tumour primarily identified in the pleura but are now 
being reported in other anatomic sites as well. SFT is generally characterised as a radiologically confined neoplasm 
composed of a proliferated spindle cells arranged in patternless manner. Intervening tissue shows prominent 
haemangiopericytoma-like vessels. Stroma is usually fibrous. Tumour is positive for CD34. SFT has a specific 
translocation representing fusion NAB2 with STAT6 genes. This translocation can be highlighted with very good 
specificity and sensitivity using STAT6 immunohistochemical stain. Some cases of SFTs have also been described in 
the breast. Rarely, SFT can show aggressive behaviour. SFT enters the differential diagnoses of benign and malignant 
spindle cell tumours of breast and it is, therefore, important that its clinical, radiological and pathological features are 
known to clinicians and diagnosticians.
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Solitary fibrous tumours (SFTs) are fibroblastic 
mesenchymal tumour primarily identified in the pleura 
but are now being reported in other anatomic sites as well 
sites including upper respiratory tract, somatic tissue, 
mediastinum and head and neck.[1] SFT is generally 
characterised as a radiologically confined neoplasm 
composed of a proliferated spindle cells arranged in 
patternless manner. Intervening tissue shows prominent 
haemangiopericytoma-like vessels. Stroma is usually 
fibrous.
We describe a case of SFT of breast that presented as 
a palpable breast mass. We have also discussed the 
differential diagnosis of neoplasm as SFT enters the 
differential diagnoses of benign and malignant spindle cell 
tumours of breast and it is, therefore, important that its 
clinical, radiological and pathological features are known 
to clinicians and diagnosticians.
Presentation of the Case
Clinical History
A 28-year-old lady presented with a lump in her left breast 
for 1 year. It measured about 6.5 × 6.0 × 4.0 cm and was 
located in the upper outer quadrant of the breast. The 
patient had complaints of pain; however, there was no 
nipple discharge. The right breast was normal on physical 
examination. Mammography and ultrasound were performed 
on the bilateral breasts and showed a mass of 6.5 × 6 × 4 cm 
in the left breast. Excision of the lump was recommended.
Gross Morphology
We received a lumpectomy specimen measuring 6.5 × 6 × 
4 cm. External surface was a bit lobulated and cut surface 
was tan white, homogeneous and also lobulated. Several 
sections were taken (one section from every centimetre) 
and processed for histological examination.
Microscopic Morphology
Microscopically, the tumour composed of spindle 
cells arranged in patternless manner with prominent 
haemangiopericytoma-like blood vessels. Stroma was 
fibrous. Cell revealed mild atypia and occasional mitotic 
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figures. Areas of necrosis, epithelial component and 
anaplastic features were not seen. Margins were pushing. At a 
greater magnification, the tumour cells showed mild increase 
in nuclear to cytoplasmic ratio and inconspicuous nucleoli. 
Immunohistochemistry
The tumour cells were diffusely positive for CD34 and 
STAT6. Other markers ERG, S100, Cytokeratin CAM5.2 
and oestrogen receptors were negative [Figure 1].
Discussion
Fibroblastic tumours affecting the mammary glands 
are very rare and represent only <0.2% of all primary 
breast lesions, with no significant difference in incidence 
between men and women.[2] The presence of large and 
solid vascular tumours, with prominent blood vessels, 
can lead the radiologist to the possible diagnosis 
of a solitary fibrous tumour.[3] The conformation of 
diagnosis requires biopsy followed by histological 
and immunohistochemical evaluation. Histologically, 
tumour is composed of a proliferated spindle cells 
arranged in patternless manner. Intervening tissue shows 
prominent haemangiopericytoma-like vessels. Stroma 
is usually fibrous. Tumour is positive for CD34. SFT 
has a specific translocation representing fusion NAB2 
with STAT6 genes. This translocation can be highlighted 
with very good specificity and sensitivity using STAT6 
immunohistochemical stain.[4]
The main differential diagnoses of SFT in the breast are 
myofibroblastoma. Even though myofibroblastomas and 
SFT of the breast share many morphological characteristics, 
there are many differences in their cytological composition. 
The immunohistochemical profile also shows that they are 
distinct entities.[5] It was initially observed in males but is 
now diagnosed with the same frequency in both men and 
women.[6] These are derived from CD34+, vimentin + and 
fibroblasts of mammary stroma capable of multidirectional 
differentiation.[7]
A: Haematoxylin and eosin 
    (H and E), × 20
B: H and E, × 4 C: H and E, × 20
D: STAT6, nuclear positivity of 
     tumour cells
E: CD34, diffuse cytoplasmic 
     positivity of tumour cells
F: Negative oestrogen 
     receptor stain
Figure 1: Histopathology of solitary fibrous tumour [A-C], Immunoprofile of solitary fibrous tumour [D-E]
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Fibromatosis is another differential diagnosis that shows 
an infiltrative pattern of fibroblasts and myofibroblasts. 
There is a noteworthy risk of local recurrence but has no 
metastatic potential. Fibromatosis is uncommon in the 
breast and occurs in <0.2% of all primary breast lesions.[8]
Another differential to consider in benign spindle cell lesions 
is nodular fasciitis. It can also occur rarely in the breast and is 
diagnosed in relatively young patients. In the cellular phase, 
it may seem cytologically as malignant due to atypia, but 
the rapid growth and recent history and positivity of actin 
and smooth muscle favour nodular fasciitis.[9]
Fibromatosis-like variant of metaplastic carcinoma 
is a low-grade variant of metaplastic carcinomas. It 
is very difficult to diagnose in needle biopsy often 
since it can mimic other neoplasms of breast cells. An 
immunohistochemical staining panel with cytokeratins 
and myoepithelial markers is a requisite for the diagnosis 
of fibromatosis-like variant of metaplastic carcinoma 
fibromatosis-like spindle cell carcinoma.[10]
Inflammatory myofibroblastic tumour is a cellular lesion 
composed of fibroblasts and myofibroblasts mixed with 
plasma cells in a collagen-rich stroma in the background.[11]
Finally, the phyllodes neoplasms can also imitate any 
proliferation of spindle cells in small biopsies. These 
tumours are composed of stromal cells with leaf-shaped 
spaces that are covered by a benign mammary glandular 
epithelium. The phyllodes tumours are classified as 
benign, borderline and malignant, depending on atypia 
in stromal cells with increased cellularity, nuclear 
pleomorphism and mitosis. Stromal cells of phyllodes 
tumours are positive for CD34, vimentin and β-catenin, 
they are negative for cytokeratin.[12]
The importance of differentiating between these above-
mentioned spindle cell tumours of the breast lies in their 
different clinical behaviour and treatment options.
Conclusion
It is important to know about pathological features of different 
spindle cell lesions of breast so that they are diagnosed and 
treated in an appropriate and recommended way.
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